Inexpensive LAMP-Based Schistosomiasis Tests Developed
By LabMedica International staff writers Posted on 12 Nov 2019 |

Image: The hand-held Genie III scanner has a two-color fluorescence excitation and detection system (Photo courtesy of OPTIGENE Ltd).
Schistosomiasis is one of the most prevalent Neglected Tropical Diseases, affecting approximately 250 million people worldwide. Schistosoma mansoni is the most important species causing human intestinal schistosomiasis.
Several polymerase chain reaction (PCR)-based molecular approaches, including conventional PCR (cPCR), real-time quantitative PCR (qPCR), droplet digital PCR (ddPCR), have been proven effective in detection of schistosome-derived DNA with more sensitivity than parasitological and serological methods, especially in chronic infections and in low transmission areas.
Scientists at the University of Salamanca (Salamanca, Spain) originally developed a loop-mediated isothermal amplification (LAMP) method for the detection of S. mansoni DNA (SmMIT-LAMP). They have now developed an important improvement for SmMIT-LAMP molecular assay, transforming it into a cold maintenance dry format suitable for potentially manufacturing as kit for ready-to-use for schistosomiasis diagnosis.
DNA from three patients’ tissue samples with microscopy-confirmed infection with S. mansoni was tested by LAMP including cutaneous and hepatic biopsies and an appendix biopsy. DNA was isolated from tissue samples using the QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany). The real-time SmMIT-LAMP reactions were performed in 8-tube Genie Strips on a portable Genie III device (OPTIGENE Ltd., Horsham, UK) at 65 °C for 60 minutes followed up by 10 minutes at 80 °C. Amplicons were confirmed on 1.5% agarose gels when required.
The team reported that endpoint results at 65–70 minutes (counting 60 minutes for reaction plus 5–10 minutes of inactivation) were clearly observed with naked eye by adding the fluorescent dye SYBR Green I post-amplification. The positive LAMP reactions turned to green; otherwise, they remained orange. Correlation of positive colorimetric results with the typical ladder of multiple bands on agarose gels was clear.
Real-time SmMIT-LAMP was carried out on a portable device using the same reaction conditions, but testing including or not betaine in the master mix. Real-time reactions worked properly in both cases and a strong correlation between the signal of the fluorescent EvaGreen dye and electrophoresis was obtained. However, removing betaine from the mixture resulted on a 10 minute reduction in the amplification time while showing identical intensity of electrophoresis bands. Both fresh and desiccated SmMIT-LAMP mixtures yielded amplification signals for S. mansoni-positive control and tissue samples. Nevertheless, a delay in the appearance of positive results and a decrease in the fluorescence signals were observed when using desiccated mixtures.
The authors concluded that the one-step dry-up protocol is simpler and faster than those previously reported and allows maintaining the functionality for at least three weeks at RT and up to five months at 4 °C. Their work demonstrated an important improvement for SmMIT-LAMP molecular assay, transformed into a cold maintenance dry format suitable for manufacturing as kit for ready-to-use for S. mansoni DNA detection. The study was published on October 14, 2019 in the journal Scientific Reports.
Related Links:
University of Salamanca
QIAGEN
OPTIGENE Ltd
Several polymerase chain reaction (PCR)-based molecular approaches, including conventional PCR (cPCR), real-time quantitative PCR (qPCR), droplet digital PCR (ddPCR), have been proven effective in detection of schistosome-derived DNA with more sensitivity than parasitological and serological methods, especially in chronic infections and in low transmission areas.
Scientists at the University of Salamanca (Salamanca, Spain) originally developed a loop-mediated isothermal amplification (LAMP) method for the detection of S. mansoni DNA (SmMIT-LAMP). They have now developed an important improvement for SmMIT-LAMP molecular assay, transforming it into a cold maintenance dry format suitable for potentially manufacturing as kit for ready-to-use for schistosomiasis diagnosis.
DNA from three patients’ tissue samples with microscopy-confirmed infection with S. mansoni was tested by LAMP including cutaneous and hepatic biopsies and an appendix biopsy. DNA was isolated from tissue samples using the QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany). The real-time SmMIT-LAMP reactions were performed in 8-tube Genie Strips on a portable Genie III device (OPTIGENE Ltd., Horsham, UK) at 65 °C for 60 minutes followed up by 10 minutes at 80 °C. Amplicons were confirmed on 1.5% agarose gels when required.
The team reported that endpoint results at 65–70 minutes (counting 60 minutes for reaction plus 5–10 minutes of inactivation) were clearly observed with naked eye by adding the fluorescent dye SYBR Green I post-amplification. The positive LAMP reactions turned to green; otherwise, they remained orange. Correlation of positive colorimetric results with the typical ladder of multiple bands on agarose gels was clear.
Real-time SmMIT-LAMP was carried out on a portable device using the same reaction conditions, but testing including or not betaine in the master mix. Real-time reactions worked properly in both cases and a strong correlation between the signal of the fluorescent EvaGreen dye and electrophoresis was obtained. However, removing betaine from the mixture resulted on a 10 minute reduction in the amplification time while showing identical intensity of electrophoresis bands. Both fresh and desiccated SmMIT-LAMP mixtures yielded amplification signals for S. mansoni-positive control and tissue samples. Nevertheless, a delay in the appearance of positive results and a decrease in the fluorescence signals were observed when using desiccated mixtures.
The authors concluded that the one-step dry-up protocol is simpler and faster than those previously reported and allows maintaining the functionality for at least three weeks at RT and up to five months at 4 °C. Their work demonstrated an important improvement for SmMIT-LAMP molecular assay, transformed into a cold maintenance dry format suitable for manufacturing as kit for ready-to-use for S. mansoni DNA detection. The study was published on October 14, 2019 in the journal Scientific Reports.
Related Links:
University of Salamanca
QIAGEN
OPTIGENE Ltd
Latest Molecular Diagnostics News
- D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism
- New Biomarkers to Improve Early Detection and Monitoring of Kidney Injury
- Chemiluminescence Immunoassays Support Diagnosis of Alzheimer’s Disease
- Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury
- Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression
- Simple DNA PCR-Based Lab Test to Enable Personalized Treatment of Bacterial Vaginosis
- Rapid Diagnostic Test to Halt Mother-To-Child Hepatitis B Transmission
- Simple Urine Test Could Help Patients Avoid Invasive Scans for Kidney Cancer
- New Bowel Cancer Blood Test to Improve Early Detection
- Refined Test Improves Parkinson’s Disease Diagnosis
- New Method Rapidly Diagnoses CVD Risk Via Molecular Blood Screening
- Blood Test Shows Promise for Early Detection of Dementia
- CRISPR-Based Diagnostic Test Detects Pathogens in Blood Without Amplification
- Portable Blood-Based Device Detects Colon Cancer
- New DNA Test Diagnoses Bacterial Infections Faster and More Accurately
- Innovative Bio-Detection Platform Improves Early Cancer Screening and Monitoring
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions
In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read moreCerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
In recent years, cancer immunotherapy has emerged as a promising approach where the patient's immune system is harnessed to fight cancer. One form of immunotherapy, called CAR-T-cell therapy, involves... Read more
New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more
Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read moreMicrobiology
view channel
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read moreInnovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
Each year, 11 million people across the world die of sepsis out of which 1.3 million deaths are due to antibiotic-resistant bacteria. The burden of antimicrobial resistance (AMR) continues to weigh heavily,... Read more
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read morePathology
view channel
AI Model Predicts Patient Response to Bladder Cancer Treatment
Each year in the United States, around 81,000 new cases of bladder cancer are diagnosed, leading to approximately 17,000 deaths annually. Muscle-invasive bladder cancer (MIBC) is a severe form of bladder... Read more
New Laser-Based Method to Accelerate Cancer Diagnosis
Researchers have developed a method to improve cancer diagnostics and other diseases. Collagen, a key structural protein, plays various roles in cell activity. A novel multidisciplinary study published... Read more
New AI Model Predicts Gene Variants’ Effects on Specific Diseases
In recent years, artificial intelligence (AI) has greatly enhanced our ability to identify a vast number of genetic variants in increasingly larger populations. However, up to half of these variants are... Read more
Powerful AI Tool Diagnoses Coeliac Disease from Biopsy Images with Over 97% Accuracy
Coeliac disease is an autoimmune disorder triggered by the consumption of gluten, causing symptoms such as stomach cramps, diarrhea, skin rashes, weight loss, fatigue, and anemia. Due to the wide variation... Read moreTechnology
view channel
Smartphones Could Diagnose Diseases Using Infrared Scans
Rapid advancements in technology may soon make it possible for individuals to bypass invasive medical procedures by simply uploading a screenshot of their lab results from their phone directly to their doctor.... Read more
Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
Metabolites are critical compounds that fuel life's essential functions, playing a key role in producing energy, regulating cellular activities, and maintaining the balance of bodily systems.... Read more
3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
Microfluidic devices are diagnostic systems capable of analyzing small volumes of materials with precision and speed. These devices are used in a variety of applications, including cancer cell analysis,... Read moreIndustry
view channel
Tecan Acquires ELISA Immunoassay Assets from Revvity's Cisbio Bioassays
Tecan Group (Männedorf, Switzerland) has entered into an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS (Codolet, France), a subsidiary of the... Read more